HOME >> BIOLOGY >> NEWS
FDG-PET imaging clearly predicts lung cancer patients' response to chemotherapy

RESTON, Va. -- An earlier indication of whether chemotherapy benefits nonsmall cell lung cancer patientsprovided by positron emission tomography (PET) imagingcan guide doctors in offering them better care, according to researchers in the May Journal of Nuclear Medicine.

Our study demonstrates that patients who respond to chemotherapy can be identified early in the course of their treatment, and these patients will generally exhibit prolonged overall survival, explained Claude Nahmias, professor of radiology and medicine at the University of Tennessee Medical Center in Knoxville. Although we studied a relatively small number of patientsand our results should be interpreted with cautionit is clear that a repeat PET study with the radiotracer fluorodeoxyglucose (FDG) at the end of the first cycle of chemotherapy would allow the identification of those patients for whom the therapy was futile, he said. The ability to provide an early indication of therapeutic response has the potential to improve patient care by identifying those patients who do not benefit from their current treatment, explained Nahmias. Patients would benefit from either having chemotherapy and its associated toxic side effects stopped or going on to a different, and hopefully more adequate, therapeutic approach, added the co-author of Time Course of Early Response to Chemotherapy in NonSmall Cell Lung Cancer Patients With 18F-FDG PET/CT.

Nonsmall cell lung cancer is the most common type of lung cancer, usually growing and spreading more slowly than small cell lung cancer. Lung cancer is the second most common cancer and the most common cause of cancer-related death in both men and women in the United States. In 2007, about 213,380 new cases of lung cancer (both small cell and non-small cell) are expected in the United States, and about 160,390 people will die of this disease. For most patients with nonsmall cell lung cancer, current treatments do not cure the cancer.

'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
9-May-2007


Page: 1 2

Related biology news :

1. New imaging method clarifies nutrient cycle
2. Methodist, University of Houston, Cornell combine biomedical imaging expertise
3. 2007 Image of the Year: Molecular imaging relates human brain chemistry to aggressive behavior
4. SNM advances professional definition for molecular imaging
5. Combining molecular imaging technologies to stop/prevent heart attacks
6. A first: Simultaneous PET/MR images of the brain debut, increase molecular imaging capabilities
7. Fusing imaging technologies creates synergy, helps diagnose heart disease accurately
8. Decoding gene expression in cancer tumors using noninvasive imaging
9. InfoSNM highlights advances in computer, information sciences for molecular imaging
10. Terahertz imaging goes the distance
11. New imaging approach promises insights into multiple sclerosis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: